Viewing Study NCT06446206


Ignite Creation Date: 2025-12-26 @ 4:04 PM
Ignite Modification Date: 2025-12-29 @ 12:55 AM
Study NCT ID: NCT06446206
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-06
First Post: 2024-05-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer
Sponsor: The First Hospital of Jilin University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module